About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,272 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,272 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1481-1500 of 4,272 trials

UnknownA Study of Olanzapine in Patients With Acute AgitationThe purpose of this study is to assess the efficacy and safety of intramuscular olanzapine for the treatment of acute agitation associated with schizophrenia and bipolar I mania.NCT05803642 CompletedAttachment-focused iMAgery Therapy for PSychosis (A-iMAPS)The relationships we have in childhood affect how we relate to others across our life, including how safe or secure we feel.NCT05042050·Manchester CompletedSafety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With SchizophreniaThe purpose of this study is to evaluate the safety and tolerability of Lu AF11167 in patients with schizophrenia following various repeated dosing regimens of Lu AF11167 (alone…NCT02202213·Glendale, California

Related Searches

Data from ClinicalTrials.govTerms

CompletedSocial Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical TrailIn the present study, we investigate healthy subjects and schizophrenic patients who frequently show very low attentional capacity with functional magnetic resonance imaging…NCT00618280·Düsseldorf, North Rhine-Westphalia and 1 other

TerminatedIndividualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal HallucinationsThe Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation that uses a magnet to change activity in the brain. rTMS uses magnetic pulses to induce an…NCT05319080·New York, New York

CompletedPartners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health ServicesHealthcare systems in the United States (U.S.) have long faced the considerable challenge of managing budgetary pressures while at the same time helping people with serious mental…NCT06053346

CompletedEarly Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisThe study will provide an empirical basis for a pharmacological treatment option. An open-label, randomized, multi-centre parallel group design is used.NCT00204061·Cologne, North Rhine-Westphalia

CompletedThe Role of Nitric Oxide in Cognition in SchizophreniaThis study evaluates the role of the Nitric Oxide system in cognition in patients with schizophrenia.NCT02906553·London

RecruitingDundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.The DUNDRUM Forensic Redevelopment Evaluation study (D-FOREST study) is a multi-site comprehensive evaluation of a complete National Forensic Mental Health Service.NCT05074732·Dublin

CompletedA Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderVarenicline (Chantix) is a smoking cessation treatment that was approved in 2006 by the FDA for treatment of nicotine dependence and may be particularly beneficial in smokers with…NCT00621777·Birmingham, Alabama and 9 others

CompletedDisturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) StudyIn this pilot study, the investigators propose to characterize the pattern of activation of the kynurenine pathway of tryptophan metabolism in peripheral macrophages of patients…NCT00573300·Boston, Massachusetts

WithdrawnAntipsychotic Discontinuation in High-risk Subjects* Would be there any difference in dopamine synthesis between remitted clinical high risk subjects for psychosis and healthy control?NCT01758887·Seoul

CompletedA Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With SchizophreniaThe purpose of this study is to evaluate the effectiveness and safety of Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) Paliperidone compared to placebo…NCT00396565·Aizu-Wakamatsu and 55 others

CompletedThe Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in SchizophreniaThe study aimed to investigate the effects of bimodal anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex (DLPFC) on…NCT03701100·Taipei

TerminatedLinks Between Perception of Temporal Order Judgment and Causality in SchizophreniaPeople with schizophrenia show disturbances in the perception of time. Among these alterations are the perturbations of the temporal order judgment.NCT03432000·Bron, Auvergne-Rhône-Alpes

CompletedSalutogenic Approach Based Interview With People With SchizophreniaThis study determines the effectiveness of the interviewing based on salutogenic approach on the sense of coherence and resilience of people with schizophrenia.NCT04740944·Istanbul

CompletedGenetic Aspects of Neurologic and Psychiatric DisordersThe purpose of this study is to improve the understanding of the genetic causes of specific neurologic and psychiatric disorders.NCT00001544·Bethesda, Maryland

RecruitingSearch for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental IllnessParticipants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe.NCT06376734·Sunnyvale, California and 1 other

CompletedLumateperone for the Prevention of Relapse in Patients With SchizophreniaThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in adult patients with a primary diagnosis of schizophrenia according to…NCT04959032·Little Rock, Arkansas and 42 others

UnknownEvaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsAs of late Integrated Care Pathways (ICPs) have been shown to improve quality of care in the medical field with special attention given to mental health in particular.NCT02529163·Toronto, Ontario

PreviousPage 75 of 214Next